- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Luteinizing Hormone Releasing Hormone (LHRH) Agonist
Total 2760 results
-
University of Colorado, DenverRecruitingHypertension | Prostate Cancer | Autonomic Dysfunction | Androgen Deprivation Therapy | Renal DiseaseUnited States
-
The Methodist Hospital Research InstituteCelgene CorporationTerminatedProstatic NeoplasmsUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...The First Affiliated Hospital of Soochow University; The Affiliated Hospital... and other collaboratorsActive, not recruitingProstatectomy | Oligometastatic Prostate Cancer | AbirateroneChina
-
Imperial College LondonWithdrawn
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedInfertility | Ovulation InductionSpain
-
BeiGeneActive, not recruitingRecurrent or Metastatic Nasopharyngeal CancerChina, Taiwan, Thailand
-
GeneScience Pharmaceuticals Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknownOvarian Hyperstimulation SyndromeChina
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyTerminated
-
New Valley UniversityCompletedProgesterone Primed Endometrial Protocol | Gonadotropin Releasing Hormone Antagonist Protocol | Assisted Reproductive TreatmentsEgypt
-
Ajjai Alva, MDHoosier Cancer Research Network; Bayer Healthcare Pharmaceuticals, Inc./Bayer...TerminatedProstate Cancer | Bone Metastases | Prostate NeoplasmsUnited States
-
Centre for Addiction and Mental HealthCompletedSubstance-Related Disorders | Cocaine-Related Disorders | Cocaine AddictionCanada
-
Celtic Pharma Development ServicesTerminated
-
Versartis Inc.Completed
-
Actavis Inc.Completed
-
Cairo UniversityUnknown
-
Cancer Research UKUnknownProstate CancerUnited Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedEmbryo Transfer | Luteal Hormone Supplementation in In-vitro FertilizationJapan
-
Shanghai First Maternity and Infant HospitalThe University of Hong KongCompleted
-
Woman's Health University Hospital, EgyptCairo UniversityUnknown
-
Dana-Farber Cancer InstituteJanssen Scientific Affairs, LLCTerminated
-
Dana-Farber Cancer InstituteJanssen PharmaceuticaActive, not recruitingProstate CancerUnited States
-
Massachusetts General HospitalNational Institute on Aging (NIA)Unknown
-
Shanghai Jiao Tong University School of MedicineUnknownIdiopathic Hypogonadotropic Hypogonadism
-
Moustafa Mohammed AboueleaRecruitingEffect of Adding GnRHa as Luteal Phase Support in Antagonist ART CyclesEgypt
-
University of NottinghamCompleted
-
University of California, San DiegoCompleted
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
University Hospital, GhentRecruitingIVF | Ovarian Reserve | Poor RespondersBelgium
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
ART Fertility Clinics LLCCompletedInfertility | Infertility, Female | IVF | hCGUnited Arab Emirates
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
Wael Elbanna ClinicNational Research Centre, EgyptRecruiting
-
Universität des SaarlandesCompleted
-
Celtic Pharma Development ServicesNeurobiological TechnologiesCompletedBrain Tumor | Brain EdemaUnited States, Canada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
Merck KGaA, Darmstadt, GermanyMerck Pte. Ltd., SingaporeCompleted
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
Washington University School of MedicineNational Cancer Institute (NCI)Not yet recruitingEndometrial Hyperplasia | Grade 1 Endometrial CancerUnited States
-
Celtic Pharma Development ServicesCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada
-
Royan InstituteUnknown
-
Celtic Pharma Development ServicesNeurobiological TechnologiesCompletedBrain Tumor | Brain EdemaUnited States, Canada
-
M.D. Anderson Cancer CenterMedivation, Inc.; Janssen Services, LLCCompletedProstate CancerUnited States
-
RenJi HospitalActive, not recruitingInflammatory Breast Cancer | Invasive Ductal Breast Cancer | Tubular Breast Cancer | Mucinous Breast CancerChina